Publication

Article

Supplements and Featured Publications
Examining the Clinical and Economic Burden of OFF Periods in Parkinson Disease
Volume 26
Issue 12

Participating Faculty

FACULTY

Caroline M. Tanner, MD, PhD

Professor, Neurology

University of California, San Francisco

Director, PADRECC

San Francisco Veterans Affairs Health Care System

San Francisco, California

Iresha Abeynayake, MPH

Associate Director of Medical Affairs and Health Outcomes Research

Acorda Therapeutics

Ardsley, New York

FACULTY DISCLOSURES

Caroline M. Tanner, MD, PhD

RESEARCH GRANT SUPPORT

Michael J. Fox Foundation; Parkinson’s Foundation; US Department of Defense; BioElectron; Roche/Genentech; Biogen Idec; National Institutes of Health

HONORARIA

Voyager Therapeutics; Intec Pharma; Biogen; Cadent Therapeutics; Neurocrine Biosciences; Adamas Therapeutics; Grey Matter; Acorda Therapeutics; Acadia; Amneal; CNS Ratings

Iresha Abeynayake, MPH

EMPLOYMENT

Acorda Therapeutics

STOCK OWNERSHIP

Acorda Therapeutics

CH LogoCenter for Biosimilars Logo